Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-12

Clinical Trial Update: Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation. [NA]

View source ↗

Summary

Clinical trial updating conversion from calcineurin inhibitors to everolimus with mycophenolic acid in liver transplant patients and its effect on long-term ren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Everolimus (everolimus)
  • Mycophenolic acid (mycophenolic acid)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Immunosuppression, Renal Failure | NA | Status: COMPLETED | Results posted: 2021-01-12